US52; Sherman Clinical Research — Sherman, Texas

US52; Sherman Clinical Research is a clinical research site located in Sherman, Texas, United States 75092.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

US52; Sherman Clinical Research has participated in 1 clinical trials.

Therapeutic areas: COPD, Smoking, Tobacco Use.

Sponsors: Philip Morris Products S.A..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman

Browse all research sites in Texas · View every site in Sherman

• Texas Cancer Center-Sherman
• Sherman Clinical Research
• Research Site
• Texas Institute for Neurological Disorders
• Texas Oncology-Sherman
• Texas Oncology, PA at Texas Cancer Center - Sherman
• Novartis Investigative Site
• GSK Investigational Site
• Texas Institute for Neurological Disorders - Sherman
• Revival Research Institute, LLC
• Clinical Trial Site
• Medrasa Clinical Research

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US52; Sherman Clinical Research?

US52; Sherman Clinical Research has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US52; Sherman Clinical Research conducted?

US52; Sherman Clinical Research has 1 clinical trials on record. Their work covers COPD, Smoking, Tobacco Use.

Is US52; Sherman Clinical Research accredited by Crixeo Clinical Trials?

US52; Sherman Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US52; Sherman Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.